First Health Stakeholders Symposium: Innovation for Health Governance

On June 18, 2008, mPedigree organized its first Health Stakeholders Symposium in collaboration with the Government of Ghana, via the Ministry of Health (MoH). The event attracted key stakeholders in leading sectors of health governance, with presentations and discussions. Over 20 media representatives were present, in addition to distinguished guests:

• Professor Alexander N. Nyarko, Director, Noguchi Memorial Institute for Medical Research
• Dr. Andreas Bjerrum, JPO, DANIDA Health Sector Advisory Office
• Mrs. Martha Gyansa-Lutterodt, Ghana National Drugs Programme/Drug Policy Development Unit, Ministry of Health.
• Dr. Marius De Jong, First Secretary for Health and Gender, and Health Lead of the joint DFID-Royal Netherlands Embassy Program
• Mr. Emmanuel Kyeremateng Agyarko, CEO, Food and Drugs Board, Ghana.

Access the presentations here:

	Download the program here
	Title: Drug Pedigree Assurance for Developing Nations: Ghana. By: Mr. Ashifi Gogo. Chief Technologist, mPedigree. Ph.D. Innovation Program Fellow, Dartmouth College. Download »
	Title: GS1 in the Healthcare Industry. By: Mr. Kofi Essuman. Chairman, GS1 Ghana. Member, Business Coalition Against Counterfeiting & Illicit Trade. Quality Assurance Manager, Unilever Ghana. Download »
	Title: Achieving MeTA Objectives in Ghana. By: Dr. Daniel Kojo Arhinful (NMIMR). Chairman, Core Group, Medicines Transparency Alliance (MeTA) Ghana. Download »

Photo Gallery

Click on an image to enlarge it.

Dr. Kojo Arhinful providing insights into MeTA's objectives in the framework of health governance.	A shot showing the cross-section of the symposium participants.
Bright Simons, eagerly following a presentation.	A section of the news media and key stakeholders, the chief pharmacist.
Mr. Ashifi Gogo, chief technologist at mPedigree, getting ready to answer questions from the media and panel after his presentation.	Panel deliberations, highlighting a passionate speech by Mr. Agyarko on the menace of fake drugs and the need to increase public-private partnerships in finding solutions to the problem.

Media Reactions

Partners